Section Arrow
EXAS.NASDAQ
- Exact Sciences Corp
Quotes are at least 15-min delayed:2025/12/28 00:21 EST
Regular Hours
Last
 101.57
+0.03 (+0.03%)
Day High 
101.7 
Prev. Close
101.54 
1-M High
102.66 
Volume 
1.25M 
Bid
101.25
Ask
101.69
Day Low
101.51 
Open
101.6 
1-M Low
100.95 
Market Cap 
19.27B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 101.61 
20-SMA 101.41 
50-SMA 83.02 
52-W High 102.66 
52-W Low 38.8118 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.35/0.76
Enterprise Value
21.75B
Balance Sheet
Book Value Per Share
13.18
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
2.76B
Operating Revenue Per Share
12.68
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OPKOPKO Health1.29-0.01-0.77%-- 
NEOGNeogen Corp7.13-0.01-0.14%879PE
PRPHProPhase Labs Inc.0.52-0.095-15.45%-- 
EXASExact Sciences Corp101.57+0.03+0.03%-- 
NEONeoGenomics12.28-0.02-0.16%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, aliquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.